Alexis Huot Daneault Mélanie Desaulniers Jean-Mathieu Beauregard Alexis Beaulieu Frédéric Arsenault Geneviève April Éric Turcotte François-Alexandre Buteau
10.3389/fendo.2021.705271
Front Endocrinol (Lausanne)
2021 Jul 22;12:705271.
177lu-dotatate prrt dosimetry metastatic cardiac paraganglioma personalized activity
CC BY
https://pubmed.ncbi.nlm.nih.gov/34367072/
Heart Neoplasms / radiotherapy Octreotide / analogs & derivatives Organometallic Compounds / therapeutic use Paraganglioma / radiotherapy Radiopharmaceuticals / therapeutic use
Heart Neoplasms / radiotherapy Octreotide / analogs & derivatives Organometallic Compounds / therapeutic use Paraganglioma / radiotherapy Radiopharmaceuticals / therapeutic use Case Reports Heart Neoplasms / pathology Heart Neoplasms / surgery Humans Male Middle Aged Octreotide / therapeutic use Paraganglioma / pathology Paraganglioma / surgery Prognosis Organometallic Compounds Radiopharmaceuticals lutetium Lu 177 dotatate Octreotide
PMC8339957
34367072
Highly Symptomatic Progressing Cardiac Paraganglioma With Intracardiac Extension Treated With 177Lu-DOTATATE: A Case Report
2021